Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial

被引：0
|
作者：
Boone T.B. [1 ]
机构：
[1] Department of Urology, The Methodist Hospital, Methodist Neurological Institute, Houston, TX, 77030, 6560 Fannin
来源：
Current Bladder Dysfunction Reports | 2011年 / 6卷 / 2期
关键词：
Botulinum Toxin; Detrusor Overactivity; Anticholinergic Medication; onabotulinumtoxinA; Urinary Urgency Incontinence;
D O I：
10.1007/s11884-011-0082-y
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：65 / 66
页数：1
相关论文
共 50 条
  • [31] OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
    Nitti, Victor W.
    Dmochowski, Roger
    Herschorn, Sender
    Sand, Peter
    Thompson, Catherine
    Nardo, Christopher
    Yan, Xiaohong
    Haag-Molkenteller, Cornelia
    JOURNAL OF UROLOGY, 2013, 189 (06): : 2186 - 2193
  • [32] Managing overactive bladder
    Robinson, D.
    Cardozo, L.
    CLIMACTERIC, 2019, 22 (03) : 250 - 256
  • [33] The treatment of overactive bladder syndrome with onabotulinumtoxinA therapy
    Majoros Attila
    Romics Miklos
    Ali Aida
    Hamvas Antal
    Molnar Peter Jozsef
    Keszthelyi Attila
    Nyirady Peter
    ORVOSI HETILAP, 2021, 162 (36) : 1459 - 1465
  • [34] Treatment for refractory overactive bladder: a systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxinA
    He, Qing
    Li, Boya
    Zhang, Chi
    Zhang, Jie
    Luo, Deyi
    Wang, Kunjie
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021, 32 (03) : 477 - 484
  • [35] 50 UNIT DOSE OF ONABOTULINUMTOXINA FOR INITIAL TREATMENT OF IDIOPATHIC OVERACTIVE BLADDER: CAN LESS BE MORE?
    Lee, W.
    Amin, K.
    Kobashi, K. C.
    LaCombe, J. A.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 : S122 - S123
  • [36] OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice
    Hamid, Rizwan
    Lorenzo-Gomez, Maria-Fernanda
    Schulte-Baukloh, Heinrich
    Boroujerdi, Amin
    Patel, Anand
    Farrelly, Elisabeth
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021, 32 (01) : 65 - 74
  • [37] OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice
    Rizwan Hamid
    Maria-Fernanda Lorenzo-Gomez
    Heinrich Schulte-Baukloh
    Amin Boroujerdi
    Anand Patel
    Elisabeth Farrelly
    International Urogynecology Journal, 2021, 32 : 65 - 74
  • [38] A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder
    Tellechea, Laura M.
    Freeman, Samantha
    Agalliu, Ilir
    Laudano, Melissa A.
    Suadicani, Sylvia O.
    Abraham, Nitya
    METABOLITES, 2022, 12 (09)
  • [39] Treatment for refractory overactive bladder: a systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxinA
    Qing He
    Boya Li
    Chi Zhang
    Jie Zhang
    Deyi Luo
    Kunjie Wang
    International Urogynecology Journal, 2021, 32 : 477 - 484
  • [40] CHANGES IN THE BRAIN CONTROL OF THE OVERACTIVE BLADDER AFTER ONABOTULINUMTOXINA
    Clarkson, Becky
    Chermansky, Christopher
    Tyagi, Shachi
    Griffiths, Derek
    Resnick, Neil
    JOURNAL OF UROLOGY, 2020, 203 : E553 - E554
12345